These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2409815)

  • 1. Effects of proglumide on ductal and basolateral secretion of pancreatic digestive enzymes.
    Niederau C; Grendell JH; Rothman SS
    Am J Physiol; 1985 Jul; 249(1 Pt 1):G100-7. PubMed ID: 2409815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini.
    Iwamoto Y; Nakamura R; Akanuma Y
    Gastroenterol Jpn; 1984 Feb; 19(1):53-8. PubMed ID: 6202584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel secretion of digestive enzymes by the in vitro rabbit pancreas.
    Steer ML; Glazer G
    Am J Physiol; 1976 Dec; 231(6):1860-5. PubMed ID: 990127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
    Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
    Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of proglumide on pancreatic acinar cell function.
    Williams JA; Bailey A; Steigerwalt RW
    Digestion; 1983; 27(4):227-33. PubMed ID: 6197332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C; Varga G; Dobronyi I; Papp M
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
    Niederau C; Niederau M; Williams JA; Grendell JH
    Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
    Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
    Iwamoto Y; Yamamoto R; Kuzuya T
    Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of various proglumide-related cholecystokinin receptor antagonists.
    Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of CR-1409 on amylase secretion and intracellular Ca2+ mobilization in rat pancreatic acini in vitro.
    Shinozaki H; Funakoshi A; Wakasugi H; Abe M
    Jpn J Physiol; 1989; 39(4):585-93. PubMed ID: 2481056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.